What is the Impact Factor of Molecular Therapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Molecular Therapy is 11.4, ranking in quartile Q1 of Web of Science (SCIE).

Is Molecular Therapy indexed in Web of Science or Scopus?

Yes, Molecular Therapy is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 3.814 (Q1) and an H-index of 233.

Who publishes Molecular Therapy and what is the Article Processing Charge (APC)?

Molecular Therapy is published by Cell Press. The estimated Article Processing Charge (APC) is approximately $4,218 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Molecular Therapy?

The official ISO-4 abbreviation of Molecular Therapy is "MOL. THER". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #461Top JournalHybrid

Molecular Therapy

Abbreviation (ISO):MOL. THER

•

Identifier (ISSN):1525-0016(Print)/1525-0024(Online)

•

Publisher:Cell Press

Official Website Submission Portal Compare

Clarivate IF (2026)

11.4↓ -0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Molecular Therapy

WoS Q1

Annual Impact Factor Metric

Current (2026):11.4

Scopus SJR & RankScopus Q1

3.814

#461

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

233

233 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate2.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

230articles/year

35.37% Gold OA•89.12% Original Research

Aims & Scope

Molecular Therapy is the leading international journal for research on the development of molecular and cellular therapeutics to correct genetic and acquired diseases, including but not limited to research on gene transfer and editing, vector development and design, stem cell manipulation, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials.

Topics Covered (Recognized by AI)

Biology99.2%Genetics92.2%Chemistry87.9%Biochemistry85.8%Medicine84.7%Gene73.8%Internal medicine55.8%Immunology45.3%Cell biology39.7%Virology37.1%Cancer research30.9%Genetic enhancement30.3%Recombinant DNA27.1%Molecular biology25.6%Cell culture23.1%Pathology22.6%

Primary Research Areas

Medicine Biotechnology & Applied Microbiology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Rank10/180

IndexSCIE

JCRSCIE2026

GENETICS & HEREDITY

Rank6/192

IndexSCIE

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank18/191

IndexSCIE

JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Rank3/180

IndexSCIE

JCISCIE2026

GENETICS & HEREDITY

Rank4/192

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank6/191

IndexSCIE

Category	Index	Rank	Quartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCRSCIE	10/180	Q1
GENETICS & HEREDITY	JCRSCIE	6/192	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	18/191	Q1
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCISCIE	3/180	Q1
GENETICS & HEREDITY	JCISCIE	4/192	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	6/191	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF11.4

Articles / Year408

Total Citations237

2025

IF12

Articles / Year607

Total Citations4,229

2024

IF12.1

Articles / Year436

Total Citations6,078

2023

IF12.4

Articles / Year289

Total Citations7,455

2022

IF12.91

Articles / Year291

Total Citations12,629

Year	Impact Factor	Articles / Year	Total Citations
2026	11.4	408	237
2025	12	607	4,229
2024	12.1	436	6,078
2023	12.4	289	7,455
2022	12.91	291	12,629
2021	11.454	318	15,209
2020	8.986	333	19,917
2019	8.402	251	17,638
2018	7.008	281	20,080
2017	—	357	32,180
2016	—	976	12,995
2015	—	972	16,065

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #461Scopus Q1SCImago Profile

Scopus Coverage:2000-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

3.814

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

8.04

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,218 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations8,788

3-Year Documents936

Citable Documents733

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate45.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ1

GeneticsQ1

Medicine (miscellaneous)Q1

Molecular BiologyQ1

Molecular MedicineQ1

PharmacologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区BIOTECHNOLOGY & APPLIED MICROBIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Therapy (abbr: MOL. THER, ISSN: 1525-0016) is a peer-reviewed international scholarly journal in the field of Medicine, published by Cell Press in United States since 2000. The periodical holds a Journal Impact Factor (JIF) of 11.4, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.814 (Q1), an H-index of 233.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 230 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,218 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.